Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients

Background: The forefront treatment of Parkinson's disease (PD) is Levodopa. When patients are treated with Levodopa cerebral blood flow is increased while cerebral metabolic rate is decreased in key subcortical regions including the putamen. This phenomenon is especially pronounced in patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Aljuaid, Maram, Booth, Samuel, Hobson, Douglas E., Borys, Andrew, Williams, Kelly, Katako, Audrey, Ryner, Lawrence, Goertzen, Andrew L., Ko, Ji Hyun
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881455/
https://ncbi.nlm.nih.gov/pubmed/31824400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.01217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados